Low‐dose hydralazine reduces albuminuria and glomerulosclerosis in a mouse model of obesity‐related chronic kidney disease

To determine, using a mouse model of obesity, whether low‐dose hydralazine prevents obesity‐related chronic kidney disease (CKD).

• Publication year

  2022

• Venue

  Diabetes, obesity and metabolism

• Publication date

  2022-05-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/dom.14778PMID 35635331PMCID 9544807
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Low‐dose hydralazine reduces albuminuria and glomerulosclerosis in a mouse model of obesity‐related chronic kidney disease

  2022cited by this paper
• Low-dose hydralazine during gestation reduces renal fibrosis in rodent offspring exposed to maternal high fat diet

  2021cited by this paper
• Novel Role of Gestational Hydralazine in Limiting Maternal and Dietary Obesity-Related Chronic Kidney Disease

  2021cited by this paper
• RIPK3 blockade attenuates tubulointerstitial fibrosis in a mouse model of diabetic nephropathy

  2020cited by this paper
• Unilateral Ureteral Obstruction as a Model to Investigate Fibrosis-Attenuating Treatments

  2019cited by this paper
• Oxidative stress in chronic kidney disease

  2018cited by this paper
• RIPK3 promotes kidney fibrosis via AKT-dependent ATP citrate lyase.

  2018cited by this paper
• Hedgehog Interacting Protein Promotes Fibrosis and Apoptosis in Glomerular Endothelial Cells in Murine Diabetes

  2018cited by this paper
• DNA methylation and the potential role of demethylating agents in prevention of progressive chronic kidney disease

  2018cited by this paper
• The renal consequences of maternal obesity in offspring are overwhelmed by postnatal high fat diet

  2017influential reference
• Obesity and kidney disease: hidden consequences of the epidemic

  2017cited by this paper
• Low-dose hydralazine prevents fibrosis in a murine model of acute kidney injury-to-chronic kidney disease progression.

  2017cited by this paper
• RIPK3 in cell death and inflammation: the good, the bad, and the ugly

  2017cited by this paper
• Obesity and kidney disease: from population to basic science and the search for new therapeutic targets.

  2017cited by this paper
• Epigenome-wide association studies identify DNA methylation associated with kidney function

  2017influential reference
• Oxidative Stress in Chronic Kidney Disease

  2016cited by this paper
• The dual roles of obesity in chronic kidney disease: a review of the current literature

  2016cited by this paper
• Mouse Models of Diabetes, Obesity and Related Kidney Disease

  2016cited by this paper
• A statistical model for the analysis of beta values in DNA methylation studies

  2016cited by this paper
• Effect of GLP-1 Receptor Activation on Offspring Kidney Health in a Rat Model of Maternal Obesity

  2016cited by this paper
• A Rationale for Epigenetic Repurposing of Hydralazine in Chronic Heart and Kidney Failure

  2016cited by this paper
• Obesity and kidney disease: hidden consequences of the epidemic

  2016influential reference
• limma powers differential expression analyses for RNA-sequencing and microarray studies

  2015cited by this paper
• Faculty Opinions recommendation of Cytosine methylation changes in enhancer regions of core pro-fibrotic genes characterize kidney fibrosis development.

  2015cited by this paper
• Albuminuria Is an Appropriate Therapeutic Target in Patients with CKD: The Pro View.

  2015cited by this paper
• Induction of Tet3-dependent Epigenetic Remodeling by Low-dose Hydralazine Attenuates Progression of Chronic Kidney Disease

  2014cited by this paper
• DNA hypermethylation and DNA hypomethylation is present at different loci in chronic kidney disease

  2014cited by this paper
• Genetic and epigenetic factors influencing chronic kidney disease.

  2014cited by this paper
• Tet3-mediated hydroxymethylation of epigenetically silenced genes contributes to bone morphogenic protein 7-induced reversal of kidney fibrosis.

  2014cited by this paper
• DNA methylation profile associated with rapid decline in kidney function: findings from the CRIC study.

  2014influential reference
• Pathophysiology of proteinuria and its value as an outcome measure in chronic kidney disease

  2013influential reference
• Gender and the prevalence and progression of renal disease.

  2013cited by this paper
• Oxidative Stress and Nucleic Acid Oxidation in Patients with Chronic Kidney Disease

  2013cited by this paper
• Obesity in CKD--what should nephrologists know?

  2013cited by this paper
• Cytosine methylation changes in enhancer regions of core pro-fibrotic genes characterize kidney fibrosis development

  2013cited by this paper
• DNA Hypermethylation and Inflammatory Markers in Incident Japanese Dialysis Patients

  2012cited by this paper
• Fast gapped-read alignment with Bowtie 2

  2012cited by this paper
• Investigating mechanisms of chronic kidney disease in mouse models

  2012cited by this paper
• Oxidative stress, anti‐oxidant therapies and chronic kidney disease

  2012cited by this paper
• Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications

  2011cited by this paper
• Hydralazine for essential hypertension.

  2011cited by this paper
• Hydralazine for essential hypertension.

  2010cited by this paper
• Dok1 mediates high-fat diet–induced adipocyte hypertrophy and obesity through modulation of PPAR-γ phosphorylation

  2008cited by this paper
• Faculty Opinions recommendation of Dok1 mediates high-fat diet-induced adipocyte hypertrophy and obesity through modulation of PPAR-gamma phosphorylation.

  2008cited by this paper
• TCF7L2 variants associate with CKD progression and renal function in population-based cohorts.

  2008cited by this paper
• Impact of inflammation on epigenetic DNA methylation – a novel risk factor for cardiovascular disease?

  2007cited by this paper
• Obesity and risk for chronic renal failure.

  2006cited by this paper
• The oxidative stress concept of nitrate tolerance and the antioxidant properties of hydralazine.

  2005cited by this paper
• [Are all antihypertensive drugs renoprotective?].

  2004cited by this paper
• Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia.

  2003cited by this paper
• Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase. A new action for an old drug.

  1996cited by this paper

• Independent and Combined Impacts of Obesity and Aging on Chronic Kidney Disease

  2025cites this paper
• Pharmaco-Epigenetics and Epigenetic Drugs in Type 2 Diabetes: Can Epigenetics Predict Drug Efficiency?

  2025cites this paper
• Epigenetics of Hypertensive Nephropathy

  2024cites this paper
• Unveiling the future of metabolic medicine: omics technologies driving personalized solutions for precision treatment of metabolic disorders.

  2023cites this paper
• Nucleic acid and protein methylation modification in renal diseases

  2023cites this paper
• Methanol extract of Inonotus obliquus improves type 2 diabetes mellitus through modifying intestinal flora

  2023cites this paper
• Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study

  2023cites this paper
• Low‐dose hydralazine reduces albuminuria and glomerulosclerosis in a mouse model of obesity‐related chronic kidney disease

  2022cites this paper